Vertex Pharmaceuticals Incorporated

10/23/2025 | Press release | Distributed by Public on 10/23/2025 07:03

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Vertex Pharmaceuticals Incorporated published this content on October 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 23, 2025 at 13:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]